marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Hepion Pharmaceuticals Cash Flow 2011-2024 | HEPA
Annual Cash Flow Hepion Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-40.9 M | -35 M | -31.2 M | -16.2 M | -7.57 M | -15.6 M | -19.2 M | -16.6 M | - | - | - | - | - |
Depreciation & Amortization |
67.1 K | 77.5 K | 86.1 K | 34.5 K | 26.7 K | 18.8 K | 28 K | 21.5 K | 16.4 K | 1.32 K | - | - | - |
Accounts Payables |
2.35 M | 2.67 M | 2.45 M | 3.72 M | 492 K | 748 K | 1.56 M | 4.25 M | 1.48 M | 244 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Hepion Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -3.62 M | - | - | - | -8.21 M | - | -30.2 M | -17.6 M | -10.1 M | - | -23.8 M | -12.5 M | -7.35 M | - | -11.6 M | -7.79 M | -4.68 M | - | -5.12 M | -3.32 M | -2.06 M | - | -10.6 M | -7.01 M | -3.59 M | - | -5.37 M | -9.46 M | -5.22 M | - | -4.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 30.8 K | - | 18.5 K | 18.3 K | 18 K | - | 17.7 K | 18.5 K | 22.7 K | - | 62.7 K | 39.6 K | 18.1 K | - | 7.2 K | 7.2 K | 6.53 K | - | 7.27 K | 8.29 K | 4.64 K | - | 14.1 K | 9.5 K | 4.86 K | - | 5.99 K | 14.9 K | 8.35 K | - | 7.05 K | 13.1 K | 7.05 K | - | 5.32 K | 10.7 K | 5.32 K | - | 2.74 K | 6.62 K | 2.74 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
186 K | 447 K | 1.5 M | 2.35 M | 3.01 M | 4.19 M | 3.17 M | 2.67 M | 2.63 M | 8.91 M | 2.38 M | 2.45 M | 1.79 M | 3.09 M | 1.66 M | 3.72 M | 3.72 M | 3.72 M | 3.72 M | 492 K | 492 K | 492 K | 492 K | 748 K | 748 K | 748 K | 748 K | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 2.3 M | 4.4 M | 4.25 M | 4.25 M | 3.16 M | 3.2 M | 1.48 M | 1.48 M | 114 K | 213 K | 244 K | 244 K | 55.5 K | 28 K | 3.62 K | 3.62 K | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency